Share on Facebook Share on Twitter Email
Answers.com

streptokinase

 
Dictionary: strep·to·kin·ase   (strĕp'tō-kĭn'ās, -āz, -kī'nās, -nāz) pronunciation
n.
A proteolytic enzyme that is produced by hemolytic streptococci, is capable of converting plasminogen to plasmin, and is used medically to dissolve blood clots.


Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Dental Dictionary: streptokinase
Top

n

A fibrinolytic activator that enhances the conversion of plasminogen to the fibrinolytic enzyme plasmin. It is used in the treatment of certain cases of pulmonary and coronary embolism.

Drug Info: Streptokinase
Top

Brand names: Streptase®



Last updated: 7/1/2002

Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.

Veterinary Dictionary: streptokinase
Top

An enzyme produced by streptococci that catalyzes the conversion of plasminogen to plasmin; abbreviated SK. Streptokinase, when administered as a thrombolytic, requires detailed and skilled control to avoid hemorrhage. It also is capable of producing severe antigenic reactions upon readministration. See also anticoagulant (2).

  • s.–streptodornase — a mixture of enzymes elaborated by hemolytic streptococci; used as a proteolytic and fibrinolytic agent.
Wikipedia: Streptokinase
Top
Streptokinase
Systematic (IUPAC) name
Streptococci streptokinase
Identifiers
CAS number 9002-01-1
ATC code B01AD01 B06AA55
PubChem  ?
DrugBank BTD00028
Chemical data
Formula C2100H3278N566O669S4 
Mol. mass 47286.7 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Streptokinase is a protein produced by beta-haemolytic streptococcus and is used as an effective and inexpensive clot-dissolving medication in some cases of myocardial infarction (heart attack)[1] and pulmonary embolism.[2]

It belongs to a group of medications known as fibrinolytics, and works by activating plasminogen through cleavage to produce plasmin.

The half life of streptokinase is approximately 20 minutes (quoted in SPC).

Contents

Mechanism of action

Plasmin is produced in the blood to break down the major constituent of blood clots fibrin, therefore dissolving clots once they have fulfilled their purpose in stopping bleeding. Extra production of plasmin caused by streptokinase breaks down unwanted blood clots, for example, in the lungs (pulmonary embolism). Streptokinase forms a complex in the plasma with plasminogen to form an activator complex. This complex then forms plasmin from unbound plasminogen.[3]

Administration

It is given intravenously as soon as possible after the onset of a heart attack (acute phase - myocardial infarction) to dissolve clots in the arteries of the heart wall. This reduces the amount of damage to the heart muscle. Streptokinase is a bacterial product so the body will build up an immunity to it. It is recommended that this medication should not be used again after four days from the first administration, as it may not be as effective and can also cause an allergic reaction. For this reason, it is usually given only for a person's first heart attack. Further thrombotic events could be treated with tPA. Overdose of streptokinase or tPA can be treated with aminocaproic acid.

Current research applications

Streptokinase may find a use in helping to prevent postoperative adhesions, a common complication of surgery, especially abdominal surgery (appendectomy, gall stones, hysterectomy, etc.) One study using animal models (rats) found that when used with a PHBV membrane drug-delivery system, it was 90 percent effective in preventing adhesions. [4]

Marketing

It is marketed in Chile as Streptase by Alpes Selection, under license of ZLB Behring from Marburg, Germany.

References

  1. ^ Sikri N, Bardia A (2007). "A history of streptokinase use in acute myocardial infarction". Tex Heart Inst J 34 (3): 318–27. PMID 17948083. 
  2. ^ Meneveau N, Schiele F, Vuillemenot A, et al. (July 1997). "Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction". Eur. Heart J. 18 (7): 1141–8. PMID 9243149. http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=9243149. 
  3. ^ Oxford Handbook of Clinical Medicine, 6th Edition.
  4. ^ A. Yagmurlu, M. Barlas, I. Gursel, I.H. Gokcora (2003). "Reduction of Surgery-Induced Peritoneal Adhesions by Continuous Release of Streptokinase from a Drug Delivery System". Eur Surg Res 35 (1): 46–49. doi:10.1159/000067035. PMID 12566787. 

 
 

 

Copyrights:

Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2009. Published by Houghton Mifflin Company. All rights reserved.  Read more
Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved.  Read more
Drug Info. Gold Standard. Copyright © 2008 by Gold Standard. All rights reserved.  Read more
Veterinary Dictionary. Saunders Comprehensive Veterinary Dictionary 3rd Edition. Copyright © 2007 by D.C. Blood, V.P. Studdert and C.C. Gay, Elsevier. All rights reserved.  Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Streptokinase" Read more